Tag: Vascular access

“More creative solutions” needed for end-stage vascular access patients

Nicholas (Nick) Inston calls for “more creative solutions” to vascular access challenges, commending interventional radiologists’ innovative reputation as instrumental to increasing the number of...
VasQ

Laminate Medical Technologies announces enrolment of first forearm patients in pivotal...

Laminate Medical Technologies has announced the enrolment of their first forearm fistula patients in their US pivotal trial of the VasQ device. VasQ is...
SAVE-US trial

SAVE-US pivotal trial completes enrollment and has positive clinical results

The SAVE-US (Surfacer system to facilitate access in venous occlusions—United States) pivotal trial has completed enrollment. The SAVE-US trial is evaluating the safety and...

The impact of paclitaxel concerns on vascular access

At the 2019 Charing Cross Symposium (CX; 15–18 April, London, UK), there was a section of the programme on drug-coated balloon trial updates which...

The role of surveillance in thrombosis treatment

As part of the CX Vascular Access Masterclass on Wednesday, Colin Deane (London, UK) considered the role of surveillance in thrombosis, asking whether there...

Comparing and contrasting surgically-created AVFs with those made by endovascular means

 Nicholas Inston (Birmingham, UK) tells Vascular News at LINC 2019 about the exciting field of percutaneous arteriovenous fistula (AVF) creation, the main devices and...
SAVE-US trial

Retrospective study finds 97% success rate with Surfacer Inside-Out access catheter

The Surfacer Inside-Out Access Catheter System (Bluegrass Vascular) has demonstrated positive commercial use, consistently achieving central venous access in patients with upper body occlusions....

Minimising arteriovenous graft infections and preserving vascular access using partial graft...

The findings of a new retrospective review carried out by Suh Min Kim (Dongguk University Ilsan Hospital, Goyang, Korea) and colleagues that aimed to...

Flow Forward Medical exceeds US$8 million investments, awarded grant from NIH

Flow Forward Medical, a medical device company focused on improving outcomes for haemodialysis patients through the rapid creation of high-quality vascular access sites, has...

The dialysis access landscape in 2018: Challenges, advances and future directions

Guidelines of the European Society for Vascular Surgery1 give an overview of the current best evidence for vascular access for dialysis. Although these guidelines...

AngioDynamics provides update on vascular access business

AngioDynamics has provided a corporate update and acknowledged a recent, favourable US District Court ruling that impacts its vascular access business. A press release states...

Japanese study investigates new device for accurate haemodialysis catheter placement

Researchers at Okayama University report in The Journal of Vascular Access the use of a supporting device for accurately placing haemodialysis catheters in dialysis...

Arteriovenous thigh graft access could be an option for haemodialysis patients

A study published recently in the Journal of Vascular Access has indicated that the use of arteriovenous thigh graft access is viable as an...

EchoNous Vein receives FDA approval

EchoNous Vein (EchoNous), an ultrasound-based tool designed specifically for nurses to improve peripheral IV catheter placements, has received US Food and Drug Administration (FDA)...

BD acquires TVA Medical, makers of everlinQ endoAVF System

BD (Becton, Dickinson and Company) announced it has completed the acquisition of TVA Medical, a company that develops minimally invasive vascular access solutions...

FDA approves Ellipsys Vascular Access System for non-surgical dialysis fistula creation

Ellipsys Vascular Access System (Avenu Medical) has been granted De Novo marketing authorisation from the Food and Drug Administration (FDA). Ellipsys is a minimally-invasive...

Humacyte appoints Jeffrey Lawson as president and CEO

Humacyte, an innovator in biotechnology and regenerative medicine, has announced that Jeffrey Lawson has been appointed president and chief executive officer. The former chairman...
SAVE-US trial

Bluegrass Vascular’s SAVE-US catheter access device trial begins enrolment

  Bluegrass Vascular Technologies has announced the enrolment of its first patients in the SAVE-US (Surfacer System to Facilitate Access in Venous Occlusions–United States) pivotal trial. The SAVE-US trial is...
VasQ

First patients enrolled in US pivotal trial of the VasQ device

The first patients have been enrolled in the US FDA pivotal study of VasQ (Laminate Medical Technologies), an implanted blood vessel external support device...

Access Vascular secures US$3.7m in financing

Access Vascular has announced US$3.7m in funding from individual investors and angelMD, an investment platform and marketplace connecting innovative medical start-ups, physicians, investors and industry partners....

Vonapanitase associated with increased fistula survival and haemodialysis use

Data from the PATENCY-1 trial indicate that the application of vonapanitase (Proteon Therapeutics) at the time of fistula surgery is associated with increased fistula...
VasQ

First four Spanish VasQ cases completed

Laminate Medical has announced the success of the first four Spanish clinical cases using the VasQ device. The cases were performed by Gaspar Mestres at...
VasQ

Laminate receives IDE approval from FDA to initiate study of the...

Laminate Medical Technologies, an Israeli biomedical start-up developing VasQ, an implanted blood vessel external support device for patients requiring arteriovenous fistula as vascular access for...

Humacyte’s Humacyl receives US FDA expedited review designation

The US Food and Drug Administration (FDA) has granted Humacyte’s Humacyl investigational human acellular vessel (HAV) Regenerative Medicine Advanced Therapy (RMAT) designation. This designation means...

Flow Forward reports Arteriovenous Fistula Eligibility system data

Flow Forward Medical has announced the completion of a preclinical study and a computational fluid dynamics study supporting continued development of the company's Arteriovenous...

Achieving haemostasis in radial artery access

The VasoStat (Forge Medical) is a haemostasis device designed for radial, brachial and transpedal procedures. The device is placed over the puncture site to...
SAVE-US trial

Bluegrass Vascular announces CE mark approval and successful commercial use of...

Bluegrass Vascular Technologies has received CE mark approval and is launching limited commercial sale of its Surfacer Inside-Out access catheter system. The Surfacer system...

AV Medical announces initial Chameleon PTA balloon catheter US experience

AV Medical has commenced cases in the USA with its Chameleon angioplasty balloon catheter. With its Supervision design, an AV Medical press release says...